Viewing StudyNCT00395252



Ignite Creation Date: 2024-05-05 @ 5:07 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00395252
Status: COMPLETED
Last Update Posted: 2015-10-02
First Post: 2006-11-01

Brief Title: Safety and Efficacy Therapy of Gemcitabine and Erbitux to R0 or R1 Resected Pancreatic Cancer
Sponsor: Carmen Schade-Brittinger
Organization: Philipps University Marburg Medical Center

Conditions & Keywords Data

Conditions:
Name
Adenocarcinoma
Keywords:
Name View
R0 or R1 resected Adenocarcinoma of the Pancreas View
pancreatic cancer View
adjuvant chemotherapy View
phase 2 View